hg_239324.1

Basic information about the TSS

---

TSS ID: hg_239324.1 Species: human Chr: chr22		Start: 24555959 End: 24555960 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000468770.1 Distance: -2 GeneID: 6634 HGNC/MGI_ID: HGNC:11160 UniProt_ID:

Gene_name: small nuclear ribonucleoprotein D3 polypeptide Gene_symbol: SNRPD3 Gene_synonyms: SMD3 Sm-D3 Gene_source: HGNC:11160

TATA-Box annotation

---

Distance to TSS:	-146
Nearest PromoterID:	NM_002156
Entrez ID:	3329
Nearest Unigene:	Hs.595053
Nearest Refseq:	NM_002156
Nearest Ensembl:	ENSG00000144381
Gene Name:	small nuclear ribonucleoprotein D3 polypeptide
Gene Alias:	CPN60|GROEL|HLD4|HSP-60|HSP60|HSP65|HuCHA60|SPG13
Gene Description:	heat shock protein family D (Hsp60) member 1
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.706468
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SNRPD3 p2@SNRPD3 p4@SNRPD3 p5@SNRPD3
Sample		p1@SNRPD3	p2@SNRPD3	p4@SNRPD3	p5@SNRPD3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	344.02	10.52	6.04	7.01
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	339.29	13.35	6.88	7.89
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	386.58	10.61	6.94	8.87
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	293.98	5.61	6.03	7.28
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	320.58	8.77	6.52	6.97
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	336.84	9.69	5.43	4.46
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	493.72	13.07	3.70	5.45
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	407.90	7.99	3.88	5.09
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	372.72	10.26	2.99	5.98
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	205.77	2.32	4.64	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	188.78	5.66	1.21	5.66
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	171.16	5.69	3.25	5.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	55.77	4.51	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	63.00	6.62	0.00	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	68.06	7.68	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	57.09	3.52	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	61.59	6.33	0.44	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	55.68	4.22	0.00	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	65.58	5.33	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	56.87	4.06	0.15	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	64.29	5.35	0.40	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	66.98	5.87	0.17	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	67.34	5.82	0.52	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	57.75	5.82	0.24	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	55.21	6.19	0.52	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	81.66	6.65	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	86.27	4.95	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	74.03	9.19	0.24	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	58.63	5.33	0.16	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	64.24	7.24	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	83.95	5.44	0.21	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	70.92	6.84	0.20	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	71.54	5.49	0.21	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	131.95	9.73	0.49	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	67.50	6.36	0.19	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	60.55	3.83	0.19	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	69.49	7.97	0.41	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	69.92	8.06	0.00	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	95.35	8.64	0.27	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	82.34	6.72	0.00	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	65.40	3.53	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	95.60	7.03	0.15	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	60.95	7.80	0.00	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	57.52	5.94	0.70	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	78.90	6.02	0.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	86.54	8.61	0.47	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	64.05	5.76	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	90.61	8.35	0.60	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	72.05	6.22	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	69.35	6.47	0.00	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	69.89	4.30	0.20	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	64.93	5.11	0.67	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	391.78	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	55.71	5.32	0.00	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	71.91	2.32	0.00	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	440.44	24.33	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	157.98	10.10	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	46.67	3.24	0.00	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	45.61	4.50	0.64	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	102.47	7.86	0.31	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	50.06	2.82	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	60.57	3.36	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	109.87	6.37	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	75.43	7.47	0.68	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	38.99	2.60	0.00	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.08	2.48	0.00	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	387.93	96.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	608.11	47.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	70.69	6.34	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	63.97	3.97	0.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	51.60	6.10	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	59.95	4.31	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	62.80	4.33	0.62	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.48	6.11	0.31	1.53
Adipocyte - breast, donor1	11376-118A8	114.51	19.32	0.00	0.48
Adipocyte - breast, donor2	11327-117E4	104.92	11.23	0.32	0.64
Adipocyte - omental, donor1	11473-119C6	129.39	17.56	0.00	0.51
Adipocyte - omental, donor2	11474-119C7	101.66	8.97	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	88.42	5.02	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	103.99	9.57	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	61.57	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	111.10	13.10	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	68.47	13.03	0.17	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	100.13	19.36	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	84.68	9.78	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	109.84	8.92	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	101.10	10.58	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	115.02	20.19	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	86.82	11.62	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	82.11	10.66	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	122.97	14.47	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	103.14	13.31	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	70.58	8.79	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	80.18	12.44	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	76.73	7.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	126.63	10.83	0.22	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	46.26	3.94	0.00	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	77.18	8.82	0.00	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	56.90	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	68.62	7.19	0.21	0.82
Anulus Pulposus Cell, donor1	11248-116E6	126.90	20.02	0.00	1.37
Anulus Pulposus Cell, donor2	11463-119B5	83.02	11.51	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	124.90	8.09	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	131.54	9.99	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	126.27	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	122.86	11.06	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	170.73	12.65	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	113.53	7.92	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	126.38	11.05	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	149.03	11.17	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	119.37	10.10	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	148.02	12.81	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	113.21	14.51	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	129.14	5.02	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	161.61	17.79	0.16	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	131.02	19.11	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	104.80	10.71	0.15	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	132.34	11.79	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	109.20	12.09	0.00	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	132.57	10.96	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	117.05	9.75	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	105.98	11.11	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	126.08	16.81	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	159.31	10.62	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	117.50	9.78	0.00	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	125.85	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	115.53	11.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	139.26	11.38	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	111.45	15.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	132.82	10.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	102.40	10.26	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	109.17	7.74	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	113.08	10.32	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	111.58	12.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	121.29	8.56	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	114.65	11.70	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	119.83	7.83	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	104.54	9.50	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	152.57	11.70	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	141.10	13.24	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	116.91	5.72	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	141.97	9.93	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	118.76	9.95	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	99.75	8.41	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	122.82	15.12	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	112.56	13.39	0.00	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	125.08	9.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	133.09	12.68	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	118.36	9.86	0.00	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	139.59	13.24	0.00	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	142.15	5.83	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	130.80	11.26	0.00	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	124.96	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	131.44	14.24	0.76	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	129.02	13.42	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	118.42	8.87	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	138.15	11.95	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	110.65	11.75	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	128.17	10.68	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	131.27	11.63	0.00	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	100.36	12.71	0.53	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	106.13	11.27	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	142.59	18.42	0.12	0.98
Astrocyte - cerebellum, donor2	11580-120F5	63.84	9.58	0.86	1.37
Astrocyte - cerebellum, donor3	11661-122F5	34.82	4.61	0.42	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	195.21	24.05	1.05	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	250.43	24.10	1.13	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	236.57	28.34	0.45	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	264.58	39.45	1.49	6.54
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	310.07	42.47	0.75	4.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	314.99	41.42	1.02	4.10
Basophils, donor1	12241-129G9	53.09	9.15	0.00	0.00
Basophils, donor2	12242-129H1	110.76	15.87	0.00	0.00
Basophils, donor3	12243-129H2	48.80	9.70	0.29	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	59.29	4.10	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	38.86	1.37	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	157.82	28.69	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	107.96	9.41	0.63	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	71.95	7.07	0.42	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	55.50	6.22	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	153.85	16.38	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	392.95	29.99	0.10	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	284.38	43.79	0.47	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	301.87	46.69	1.60	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	320.60	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	55.79	10.14	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	54.38	5.01	0.93	1.86
CD14+ Monocytes, donor3	11381-118B4	53.79	6.59	1.32	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	86.05	13.87	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	93.63	17.44	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	98.95	23.01	0.00	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	56.23	7.81	0.43	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	54.01	7.24	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	75.57	8.05	0.47	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	47.04	6.19	0.84	2.18
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	53.82	5.52	0.55	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	70.66	7.69	0.50	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	41.31	6.85	0.39	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	44.33	7.66	0.53	2.14
CD14+ monocytes - treated with BCG, donor3	11880-125C8	87.05	9.36	0.22	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	41.67	5.85	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	58.08	7.92	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	71.00	9.98	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	45.37	6.10	1.04	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	65.85	6.78	0.20	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	100.77	8.12	0.00	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	48.96	6.63	0.92	1.83
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	64.47	8.37	0.23	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	59.36	5.67	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	45.19	5.65	0.54	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	56.00	6.98	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	69.01	10.10	0.42	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	37.84	4.96	0.18	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	50.73	1.76	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	54.40	4.83	0.00	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	38.71	4.01	0.17	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	49.80	7.43	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	86.00	12.07	0.22	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	51.19	4.50	1.23	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.47	7.42	1.16	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	63.80	8.12	0.93	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	206.19	34.22	0.65	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	181.10	28.87	0.46	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	195.39	30.98	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	219.72	32.39	0.00	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	172.37	28.12	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	224.75	35.01	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	214.09	41.85	0.77	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	185.31	30.08	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	196.44	32.63	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	264.20	38.61	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	267.12	40.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	257.86	41.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	261.72	42.11	1.07	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	288.40	43.42	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	252.70	30.89	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	282.37	46.28	0.00	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	333.53	50.09	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	115.07	13.97	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	88.50	8.71	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	79.76	7.57	0.00	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	692.55	94.15	1.21	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	475.79	62.72	2.40	0.80
CD34+ Progenitors, donor1	11545-120B6	148.60	18.07	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	134.27	13.48	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	293.09	49.98	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	419.62	60.43	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	78.91	14.28	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	73.48	12.86	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	91.50	10.67	0.30	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	214.65	34.97	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	183.50	34.14	0.22	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	163.28	25.01	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	261.70	35.08	0.47	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	289.36	29.50	0.70	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	207.66	19.78	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	212.44	36.13	0.14	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	129.64	18.30	0.51	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	116.71	18.22	0.32	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	190.53	22.86	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	231.99	32.49	0.35	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	189.63	30.36	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	328.04	39.63	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	168.50	25.35	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	200.81	28.40	1.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	253.71	33.45	0.54	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	294.24	37.52	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	252.84	30.48	1.79	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	287.04	41.72	0.93	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	204.92	30.98	0.65	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	183.67	32.78	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	251.79	37.41	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	262.98	35.09	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	300.71	34.87	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	240.01	40.58	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	282.49	53.54	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	314.06	40.48	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	333.42	52.34	0.83	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	392.87	60.12	0.00	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	337.26	36.96	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	276.11	50.85	1.07	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	279.77	56.78	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	91.34	10.48	0.33	0.98
CD8+ T Cells, donor2	11307-117C2	82.60	12.01	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	78.02	12.12	0.76	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	154.15	13.53	1.15	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	154.09	12.46	0.72	2.16
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	183.03	15.05	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	227.56	21.31	0.90	2.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	155.51	13.44	0.72	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	153.26	13.42	0.68	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	222.06	17.60	0.65	3.26
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	223.46	15.79	1.05	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	224.43	15.48	0.70	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	262.03	21.43	1.21	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	281.21	20.34	0.58	5.52
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	237.66	14.92	1.07	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	110.75	6.13	1.31	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	115.68	8.65	1.82	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	70.11	5.22	0.75	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	146.58	8.28	0.36	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	134.08	13.52	0.58	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	126.33	10.37	0.94	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	211.69	19.96	0.63	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	194.38	16.92	1.23	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	197.80	16.03	1.60	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	214.95	14.53	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	184.84	14.98	1.58	3.94
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	214.07	12.10	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	105.19	13.65	2.41	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	96.52	13.29	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	112.20	7.01	2.00	4.01
Cardiac Myocyte, donor1	11525-119I4	82.25	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	165.03	12.35	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	132.91	21.36	0.11	0.32
Chondrocyte - de diff, donor1	11261-116G1	146.99	19.07	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	63.26	5.69	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	115.49	15.25	0.11	0.68
Chondrocyte - re diff, donor2	11339-117F7	160.25	27.75	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	81.69	8.49	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	216.66	33.28	0.46	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	164.17	22.66	0.21	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	158.68	21.86	0.00	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	109.03	18.43	0.37	2.02
Corneal Epithelial Cells, donor1	11526-119I5	54.89	5.49	0.00	0.66
Corneal Epithelial Cells, donor2	11606-120I4	110.35	10.24	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	109.15	8.69	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	82.88	14.36	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	73.81	11.04	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	106.97	17.25	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	76.35	11.23	0.00	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	108.98	20.16	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	150.16	29.38	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	155.83	16.94	0.97	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	79.22	9.01	0.33	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	96.82	7.63	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	98.98	11.31	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	94.76	7.08	0.39	2.36
Endothelial Cells - Artery, donor1	11264-116G4	130.31	10.76	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	231.04	24.00	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	99.93	13.32	0.35	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	110.83	21.50	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	135.09	24.65	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	147.72	21.71	0.00	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	105.78	13.37	0.30	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	75.50	8.33	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	69.48	11.20	0.28	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	290.49	23.21	1.20	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	103.25	8.39	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	403.68	42.00	0.25	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	199.88	18.90	0.22	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	248.41	22.11	0.12	0.85
Endothelial Cells - Vein, donor1	11267-116G7	97.83	7.96	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	78.23	7.68	0.00	2.10
Endothelial Cells - Vein, donor3	11416-118F3	121.99	15.07	0.47	1.10
Eosinophils, donor1	12244-129H3	106.73	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	44.56	4.95	1.65	0.00
Eosinophils, donor3	12246-129H5	42.80	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	49.11	6.35	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	69.79	11.08	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	78.50	8.10	0.00	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	112.56	13.54	0.43	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	181.43	23.29	0.24	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	102.76	15.97	0.00	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	105.05	11.60	0.11	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	83.26	13.17	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	139.86	17.27	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	96.17	11.79	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	64.43	6.82	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	122.70	15.14	0.00	0.63
Fibroblast - Cardiac, donor4	11452-119A3	149.43	26.67	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	135.79	17.26	0.38	0.51
Fibroblast - Cardiac, donor6	11460-119B2	175.09	20.47	0.45	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	94.06	13.40	0.54	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	101.82	13.81	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	238.76	33.69	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	61.35	11.53	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	134.50	20.86	0.51	0.68
Fibroblast - Dermal, donor1	11269-116G9	125.14	12.91	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	112.26	13.21	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	128.50	15.35	0.00	0.85
Fibroblast - Dermal, donor4	11450-119A1	194.55	20.46	0.11	0.90
Fibroblast - Dermal, donor5	11454-119A5	268.31	24.07	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	311.85	28.10	0.16	0.97
Fibroblast - Gingival, donor1	11237-116D4	153.67	26.65	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	132.31	20.44	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	251.97	26.62	0.53	1.05
Fibroblast - Gingival, donor3	11394-118C8	102.49	17.60	0.00	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	85.19	18.70	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	63.96	11.63	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	240.24	25.72	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	217.04	20.01	0.14	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	110.10	14.47	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	181.49	21.64	0.00	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	237.80	23.45	0.41	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	245.49	23.25	0.55	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	93.91	12.62	0.00	0.59
Fibroblast - Lung, donor1	11270-116H1	42.14	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	153.69	25.37	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	186.34	20.47	0.63	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	151.61	10.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	83.92	5.59	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	27.15	4.20	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	179.03	17.86	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	87.87	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	53.61	23.83	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	233.16	33.95	0.19	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	329.00	28.82	0.76	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	243.57	34.27	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	128.99	16.03	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	147.68	18.63	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	63.79	8.58	0.12	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	256.21	34.93	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	121.51	14.63	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	100.23	14.03	0.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	149.45	22.54	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	134.15	11.71	1.19	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	116.34	15.28	0.53	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	179.94	22.86	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	118.24	14.14	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	239.22	28.72	0.00	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	116.67	11.14	0.76	0.76
Fibroblast - skin normal, donor1	11553-120C5	148.16	19.85	0.33	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	110.48	14.64	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	247.44	29.54	0.00	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	157.16	12.69	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	145.31	24.36	0.00	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	207.19	29.57	0.17	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	117.91	10.18	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	244.36	27.27	0.11	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	218.95	20.75	0.00	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	186.30	20.70	0.16	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2725.65	398.88	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	88.90	11.33	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	169.02	13.70	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	229.27	19.26	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	210.54	16.86	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	331.48	22.20	0.77	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	536.62	27.44	5.10	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	565.11	45.64	2.00	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	196.89	27.02	1.10	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	155.72	19.64	2.05	2.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	321.96	34.87	1.39	3.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	204.86	23.53	1.59	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	110.24	20.55	2.61	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	493.52	37.15	1.77	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	470.89	35.61	1.13	2.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	345.66	23.64	0.86	1.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	463.92	30.62	1.07	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	346.53	22.30	1.24	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	392.72	23.67	0.97	3.05
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	434.25	23.79	0.20	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	274.96	15.29	0.00	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	245.52	20.43	1.25	1.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	219.45	22.29	0.00	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	329.46	23.34	1.18	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	296.62	22.89	0.48	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	272.80	20.78	0.45	2.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	300.84	24.40	0.60	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	316.21	29.52	1.36	3.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	441.06	39.99	1.06	1.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	398.85	47.24	1.04	2.29
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	444.02	43.38	0.34	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	241.34	24.34	0.89	2.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	329.12	38.44	0.83	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	378.76	39.41	1.02	2.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	267.58	28.88	0.41	2.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	216.75	23.29	1.38	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	261.82	25.68	0.67	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	216.24	25.13	0.22	2.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	232.09	24.72	0.98	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	242.17	22.21	1.30	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	232.20	21.49	0.96	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	194.34	21.79	0.76	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	212.43	15.50	0.32	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	233.84	22.20	0.91	3.34
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	210.44	20.91	1.15	2.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	186.62	17.34	0.66	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	197.79	23.57	1.40	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	166.19	17.68	0.19	1.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	265.00	20.86	0.53	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	217.27	20.20	0.61	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	205.06	19.04	0.52	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	163.46	18.70	1.08	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	205.37	19.91	0.18	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	167.99	19.30	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	150.75	13.88	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	198.79	16.36	0.66	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	167.46	21.59	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	181.22	24.65	0.51	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	839.04	59.72	1.19	1.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	473.32	34.82	0.92	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	637.89	43.99	1.02	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	663.72	55.39	3.44	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	626.71	45.49	1.41	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	520.70	34.13	0.00	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	492.48	27.22	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	470.75	40.61	2.32	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	436.42	33.69	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	427.75	38.25	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	380.49	29.94	0.65	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	460.81	44.89	1.65	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	343.22	39.99	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	359.07	34.40	1.12	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	408.23	28.11	1.31	5.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	353.99	40.26	0.84	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	361.65	36.26	0.95	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	419.14	37.02	1.36	3.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	476.10	41.76	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	465.60	38.94	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	272.01	23.09	1.18	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	381.18	28.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	442.37	32.72	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	360.84	31.99	1.84	3.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	337.18	15.81	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	296.38	26.14	1.15	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	280.99	24.77	2.61	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	337.10	21.40	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	311.68	31.59	1.54	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	293.39	27.39	2.40	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	226.12	2.48	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	258.57	21.23	0.47	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	254.07	22.93	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	288.42	25.43	1.02	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	277.59	29.91	0.80	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	327.09	30.09	0.99	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	292.75	15.35	0.00	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	264.30	20.42	1.17	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	241.39	21.07	1.32	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	192.43	13.56	1.70	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	222.65	21.49	1.19	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	230.01	16.50	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	62.77	9.13	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	84.41	11.64	0.42	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	71.97	10.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	83.73	8.25	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	85.64	8.77	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	435.62	35.97	0.46	1.74
Hep-2 cells mock treated, biol_rep2	11899-125E9	424.70	31.06	0.84	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	387.89	33.44	0.00	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	432.10	42.52	0.55	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	432.83	36.96	1.07	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	378.68	38.75	0.86	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	425.54	39.35	0.62	2.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	441.57	32.59	0.17	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	380.28	28.83	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	90.66	7.28	0.56	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	52.37	3.46	0.43	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	327.83	7.93	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	58.20	9.52	0.00	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.13	2.91	0.00	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	200.02	18.36	0.00	1.05
Hepatocyte, donor1	11523-119I2	196.12	13.32	0.00	1.21
Hepatocyte, donor2	11603-120I1	226.24	8.62	0.00	2.15
Hepatocyte, donor3	11684-122I1	122.71	12.27	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	691.19	45.04	4.57	7.83
Intestinal epithelial cells (polarized), donor1	11246-116E4	348.17	30.06	0.52	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	168.22	25.11	0.14	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	70.05	15.92	0.00	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	80.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	69.22	4.15	1.38	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	90.10	7.51	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	23.74	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	5.13	0.00	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	86.84	9.14	0.00	18.28
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	102.33	9.75	0.00	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	115.04	11.67	5.00	10.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	112.55	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	66.17	10.59	3.97	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	88.69	8.87	1.11	7.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	0.00	0.00	20.95
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	125.34	17.01	3.78	3.78
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	64.96	6.19	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	106.60	11.63	3.88	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	69.23	11.27	3.22	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	100.23	17.11	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	75.57	9.24	1.68	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	114.12	20.90	2.41	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	92.33	7.39	0.00	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	109.98	13.22	0.47	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	71.65	8.16	0.91	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	125.91	11.84	1.08	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	71.15	8.89	0.00	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	107.77	16.58	2.55	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	65.62	16.40	0.00	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	112.11	16.42	0.71	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	86.28	16.59	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	123.77	12.96	0.62	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	87.80	8.78	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	9.43	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	92.49	10.43	0.00	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	97.38	4.43	0.00	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	126.44	9.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	84.58	6.98	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	80.99	11.25	2.25	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	75.74	11.73	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	70.66	16.63	1.39	6.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	2.85	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	77.32	8.28	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	6.05	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	61.33	5.29	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	225.78	14.04	0.16	0.08
Keratinocyte - epidermal, donor2	11349-117G8	43.34	4.10	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	268.44	20.82	0.38	0.19
Keratinocyte - oral, donor1	11251-116E9	335.56	33.71	0.23	0.57
Keratocytes, donor1	11527-119I6	86.30	15.13	0.00	0.69
Keratocytes, donor2	11607-120I5	82.03	9.37	0.00	1.17
Keratocytes, donor3	11688-122I5	89.91	12.45	0.20	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	90.11	26.37	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	177.99	12.94	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	154.89	26.30	0.35	0.92
Lens Epithelial Cells, donor3	11690-122I7	101.01	18.87	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	171.34	27.75	0.12	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	130.61	14.79	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	178.19	18.26	0.47	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	157.55	14.52	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	99.91	11.98	0.00	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	118.16	15.31	0.32	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	160.46	13.13	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	85.20	9.10	0.00	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	122.17	14.22	0.56	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	149.91	12.66	0.40	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	148.52	19.39	0.00	2.33
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	76.28	9.26	0.00	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	157.84	17.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	145.74	15.50	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	120.04	13.46	0.55	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	151.82	19.40	0.31	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	98.51	7.48	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	118.39	14.46	0.55	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	152.05	18.10	0.66	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	106.31	13.47	1.17	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	89.86	10.46	0.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	170.71	18.43	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	150.27	18.31	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	146.23	13.47	0.30	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	149.82	16.07	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	158.72	18.22	1.05	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	131.43	14.59	0.60	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	170.59	16.51	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	136.41	10.72	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	102.85	10.71	0.42	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	149.25	13.57	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	127.02	15.55	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	105.18	10.65	0.37	1.86
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	163.26	15.55	0.74	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	154.43	17.30	0.00	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	105.60	9.07	0.27	1.51
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	140.56	12.87	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	164.03	16.13	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	169.50	22.39	0.56	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	155.74	16.00	0.36	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	123.62	12.60	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	76.56	8.71	0.16	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	153.63	16.83	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	137.53	9.80	1.31	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	80.99	8.95	0.71	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	160.01	17.94	0.25	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	81.96	10.76	0.26	2.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	106.81	11.93	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	115.57	9.06	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	105.10	12.27	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	101.69	11.13	1.48	4.45
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	118.05	11.42	2.96	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	99.87	13.36	2.81	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	95.26	9.34	0.93	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	130.36	5.67	1.03	4.12
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	89.21	5.95	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	112.64	15.38	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	152.68	13.67	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	154.41	11.70	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	132.37	16.66	1.22	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	124.27	5.65	3.59	5.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	110.09	12.00	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	125.93	9.99	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	133.97	9.17	3.06	4.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	136.34	12.54	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	144.92	13.23	0.76	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	124.55	6.14	0.00	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	132.10	7.34	1.63	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	139.11	7.50	1.04	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	141.81	12.05	1.40	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	87.58	10.30	1.03	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	134.41	10.16	1.45	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	151.26	13.75	1.49	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	148.27	9.96	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	107.11	8.13	1.41	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	137.55	9.22	1.11	3.32
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	128.94	3.45	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	116.66	9.59	1.15	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	108.13	9.06	1.13	5.66
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	125.53	13.13	0.82	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	103.93	7.23	2.26	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	127.83	12.93	0.72	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	130.71	8.22	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	105.90	13.01	1.11	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	124.92	6.89	1.72	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	109.61	16.27	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	121.94	12.33	1.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	111.01	9.05	3.02	6.64
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	87.45	14.93	0.71	4.27
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	101.74	11.00	1.03	5.84
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	108.42	5.37	2.15	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	103.02	12.79	0.00	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	112.23	9.63	1.85	4.07
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	134.90	6.98	2.33	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	86.73	5.29	1.06	5.29
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	108.04	8.80	1.60	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	95.95	10.90	2.18	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	76.65	6.13	3.07	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	101.62	8.88	2.47	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	113.85	16.94	4.70	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	92.02	11.06	3.52	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	105.45	9.46	0.90	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	151.46	1.72	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	101.98	15.14	1.34	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	107.53	8.21	0.39	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	108.20	3.96	0.66	3.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	113.64	8.30	0.52	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	109.83	7.44	2.19	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	115.73	10.06	3.35	3.91
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	96.28	13.25	1.32	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	104.91	7.71	1.54	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	103.80	8.61	0.00	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	96.60	8.65	1.92	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	117.28	9.94	1.19	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	105.12	9.11	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	133.50	10.38	0.69	5.53
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	114.00	10.64	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	119.81	6.71	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	110.65	10.28	0.60	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	109.96	7.92	0.63	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	117.81	4.26	0.00	4.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	124.70	5.75	1.72	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	112.62	12.86	0.00	4.63
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	121.66	7.78	2.12	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	125.41	8.51	1.70	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	116.07	7.49	2.08	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	137.03	10.18	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	143.22	9.19	2.51	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	113.37	7.90	0.93	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	114.41	13.38	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	126.18	8.02	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	107.09	10.51	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	91.78	10.10	2.75	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	121.81	7.11	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	111.69	9.12	1.14	3.42
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	126.54	9.97	1.53	6.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	159.23	12.59	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	103.34	8.02	1.34	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	114.12	8.58	0.52	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	131.96	11.27	1.99	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	126.80	8.31	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	70.20	15.27	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	73.04	14.68	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	81.14	11.14	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	289.94	13.28	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	303.12	20.44	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	432.81	23.49	0.14	1.25
Mammary Epithelial Cell, donor1	11273-116H4	108.11	21.42	0.50	1.10
Mammary Epithelial Cell, donor2	11350-117G9	214.27	24.03	0.29	1.16
Mammary Epithelial Cell, donor3	11422-118F9	87.55	7.48	0.25	1.00
Mast cell - stimulated, donor1	11487-119E2	448.79	78.64	0.68	0.00
Mast cell, donor1	11563-120D6	133.01	32.55	0.22	0.76
Mast cell, donor2	11565-120D8	92.72	16.05	0.00	1.19
Mast cell, donor3	11566-120D9	81.72	26.34	0.23	0.45
Mast cell, donor4	11567-120E1	80.31	20.74	0.53	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	205.26	42.25	0.22	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	255.65	36.77	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	221.07	42.22	0.34	0.92
Mast cell, expanded, donor8	11941-126A6	148.96	24.10	0.33	1.00
Melanocyte - dark, donor1	11502-119F8	266.46	40.30	0.30	0.90
Melanocyte - dark, donor2	11582-120F7	141.20	14.19	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	205.01	34.34	0.29	0.43
Melanocyte - light, donor1	11274-116H5	44.19	7.05	0.24	0.47
Melanocyte - light, donor2	11351-117H1	37.54	6.14	0.00	1.36
Melanocyte - light, donor3	11423-118G1	34.69	3.47	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	239.28	24.57	0.10	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	194.98	15.87	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	167.14	12.59	0.27	0.27
Meningeal Cells, donor1	11493-119E8	244.52	29.40	0.50	1.12
Meningeal Cells, donor2	11573-120E7	176.94	21.57	0.44	1.76
Meningeal Cells, donor3	11654-122E7	454.13	57.78	0.73	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	203.03	27.37	0.29	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	124.38	18.21	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	2.63	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	82.41	7.85	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	233.22	20.81	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	105.04	17.58	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	118.12	12.06	0.00	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	94.27	12.09	0.44	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	121.28	9.50	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	74.48	7.57	0.61	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	126.04	18.84	0.55	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	49.07	5.95	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	167.76	21.45	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	54.90	9.20	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	4.67	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	100.54	13.45	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	247.40	35.80	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	121.02	17.20	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	220.61	17.42	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	115.09	11.40	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	134.63	13.01	0.00	1.50
Mesothelial Cells, donor3	11402-118D7	107.82	11.27	0.00	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	9.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	82.99	11.08	0.25	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	70.08	10.89	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	59.51	9.61	0.31	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	73.85	11.41	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	68.82	8.76	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	65.17	10.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	70.11	10.36	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	55.04	7.52	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	72.56	5.31	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	88.91	9.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	75.55	10.82	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	47.09	5.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	69.00	9.53	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	52.76	8.32	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	19.35	3.87	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	67.23	8.75	0.00	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	61.42	9.04	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	50.35	6.73	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	66.94	9.87	0.64	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	54.68	8.89	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	49.28	8.32	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	4.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	48.38	6.25	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	57.05	6.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	54.78	4.81	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	54.03	5.60	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	44.05	5.01	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	65.25	7.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	21.77	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	77.85	5.21	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	21.57	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	76.92	6.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.51	2.19	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.60	2.49	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	93.42	9.54	0.28	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	41.15	3.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	20.40	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	53.70	5.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	65.53	9.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	54.49	5.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	64.88	7.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	52.23	4.84	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	80.60	7.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	64.35	5.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	3.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	51.24	5.07	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	71.54	8.08	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	46.76	6.50	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	86.32	4.78	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	75.85	8.18	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.47	2.65	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	96.60	10.51	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	81.61	8.36	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	21.51	2.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	81.15	6.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	85.06	10.09	0.00	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	88.61	9.48	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	59.85	7.15	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	11.30	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	87.33	5.35	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	92.66	13.47	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	72.58	9.47	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	76.90	13.05	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	65.19	11.18	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	79.61	15.02	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	63.66	7.99	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	97.61	14.82	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	44.94	11.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	79.15	11.73	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	91.78	14.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	152.31	21.91	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	7.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	42.42	7.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	81.38	11.38	0.00	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	85.80	10.90	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	82.65	11.44	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	124.71	17.82	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	69.48	12.08	0.00	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	5.71	0.00	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	137.02	9.79	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	104.55	19.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	156.84	19.39	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	125.43	24.04	0.00	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	40.72	2.67	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.46	2.92	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	121.88	12.93	0.19	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	86.18	7.98	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.88	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	271.97	22.05	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	34.32	2.09	0.84	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	53.93	6.04	0.00	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	35.40	5.13	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	73.58	5.47	0.00	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	445.39	55.67	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	54.10	5.46	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	51.43	2.98	0.00	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	33.32	2.27	0.45	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.27	3.10	0.33	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	83.11	8.20	0.18	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	42.97	2.12	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.81	3.60	0.00	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	103.05	10.50	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.58	2.93	0.16	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	73.37	8.47	0.71	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.16	6.33	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	30.34	4.60	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	36.63	5.14	0.00	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	113.12	14.49	0.34	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	260.43	45.51	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	64.61	6.46	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.87	5.08	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	31.81	4.75	0.00	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	39.06	6.01	1.29	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	577.78	99.31	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.32	7.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.05	4.51	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.04	6.35	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	42.72	5.57	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.32	7.19	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	29.98	3.26	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.00	1.74	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	75.08	7.69	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	41.45	5.29	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	34.57	5.32	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	46.13	7.44	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.97	4.21	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	61.70	8.77	0.00	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	86.64	7.96	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	41.34	4.07	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	255.48	40.88	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	40.85	6.71	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.66	4.09	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	24.21	3.63	0.61	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	6.33	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	122.43	15.87	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	455.21	65.75	0.00	0.00
Myoblast, donor1	11241-116D8	164.35	20.62	0.37	0.37
Myoblast, donor2	11322-117D8	145.57	19.56	0.38	1.15
Myoblast, donor3	11398-118D3	155.05	29.09	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	212.04	21.60	0.44	1.31
Natural Killer Cells, donor1	11230-116C6	86.10	15.38	0.62	1.54
Natural Killer Cells, donor2	11311-117C6	64.23	5.43	1.21	2.11
Natural Killer Cells, donor3	11387-118C1	78.22	11.41	0.74	2.21
Neural stem cells, donor1	11275-116H6	352.41	40.29	0.00	0.73
Neural stem cells, donor2	11352-117H2	360.10	30.81	1.93	0.00
Neurons, donor1	11494-119E9	226.44	33.00	1.14	4.55
Neurons, donor2	11574-120E8	191.10	30.38	0.44	1.32
Neurons, donor3	11655-122E8	206.36	23.02	0.00	4.11
Neutrophils, donor1	11233-116C9	46.40	8.35	0.00	3.71
Neutrophils, donor2	11314-117C9	40.58	5.80	2.90	0.00
Neutrophils, donor3	11390-118C4	40.93	10.38	0.61	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	123.37	20.78	0.12	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	83.68	8.14	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	87.24	12.03	0.00	1.40
Olfactory epithelial cells, donor1	11933-125I7	68.14	12.66	0.28	2.48
Olfactory epithelial cells, donor2	11934-125I8	112.32	13.61	0.00	1.16
Olfactory epithelial cells, donor3	11935-125I9	82.75	11.69	0.23	0.68
Olfactory epithelial cells, donor4	11936-126A1	97.98	12.95	0.10	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	244.94	19.86	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	42.96	8.93	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	60.58	5.72	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	54.62	11.79	0.00	1.24
Osteoblast, donor1	11277-116H8	69.38	9.19	0.20	1.56
Osteoblast, donor2	11354-117H4	266.18	30.20	0.00	4.21
Osteoblast, donor3	11426-118G4	83.71	7.29	0.36	0.71
Pancreatic stromal cells, donor1	11249-116E7	158.87	20.47	0.08	0.42
Pericytes, donor1	11491-119E6	42.62	6.34	0.11	1.00
Pericytes, donor2	11571-120E5	36.90	7.70	0.23	1.81
Pericytes, donor3	11652-122E5	68.36	8.54	0.41	0.81
Perineurial Cells, donor1	11499-119F5	204.68	30.74	0.45	0.34
Perineurial Cells, donor2	11579-120F4	189.36	27.60	0.00	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	123.03	18.17	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	72.97	8.57	0.98	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	93.31	12.17	0.52	1.04
Placental Epithelial Cells, donor1	11278-116H9	111.21	14.35	1.20	0.72
Placental Epithelial Cells, donor2	11355-117H5	159.68	26.61	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	129.38	11.58	0.39	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	91.77	4.43	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	125.68	13.13	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	83.93	13.18	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	106.50	10.58	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	118.28	16.41	0.32	0.21
Preadipocyte - omental, donor2	11329-117E6	117.85	24.88	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	102.71	12.61	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	74.80	7.87	0.00	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	52.82	5.84	0.31	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	339.99	30.81	0.18	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	210.47	22.65	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	246.84	27.57	0.37	0.37
Preadipocyte - visceral, donor2	11357-117H7	230.09	23.01	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	199.26	17.45	0.21	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	267.61	25.04	1.36	0.91
Prostate Epithelial Cells, donor2	11331-117E8	133.11	9.61	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	130.56	14.33	0.37	0.49
Prostate Stromal Cells, donor1	11254-116F3	212.54	29.39	0.23	0.80
Prostate Stromal Cells, donor2	11332-117E9	197.05	19.90	0.18	0.72
Prostate Stromal Cells, donor3	11405-118E1	109.18	13.76	0.73	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	66.06	5.47	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	206.27	15.32	0.14	1.04
Renal Epithelial Cells, donor1	11517-119H5	43.62	6.59	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	91.76	6.40	0.71	2.13
Renal Epithelial Cells, donor3	11678-122H4	232.27	21.38	0.21	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	47.66	6.13	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	105.79	9.30	0.40	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	240.88	21.31	0.67	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	57.89	5.32	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	66.25	7.92	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	74.61	8.15	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	35.79	4.16	0.00	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	131.80	9.39	0.00	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	69.16	3.80	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	91.60	9.64	0.39	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	198.35	25.15	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	91.53	11.37	0.28	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	84.39	7.20	0.00	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	208.00	22.33	0.25	1.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	137.64	15.37	0.53	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	137.58	12.51	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	460.66	30.27	2.75	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	207.66	15.66	0.58	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	468.61	34.59	0.39	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	305.46	28.00	1.29	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	402.66	40.38	1.23	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	529.66	49.49	0.87	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	347.19	29.02	0.82	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	424.59	35.13	0.92	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	345.69	26.42	1.37	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	320.70	26.78	1.21	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	288.32	31.00	1.25	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	346.73	30.27	1.86	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	335.36	27.47	0.75	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	335.00	28.32	1.33	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	390.19	25.24	0.76	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	291.60	26.55	0.75	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	495.14	46.41	1.13	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	295.54	18.84	1.06	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	342.74	29.88	0.97	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	371.03	31.70	1.15	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	331.49	20.18	0.96	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	318.43	26.07	0.56	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	342.31	29.57	1.37	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	307.23	20.42	1.46	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	321.91	26.61	1.72	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	357.43	27.40	1.34	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	463.96	28.07	1.42	2.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	330.95	28.37	0.99	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	372.05	26.19	1.17	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	338.40	28.62	1.24	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	435.34	30.31	1.77	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	328.78	21.72	3.13	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	369.17	32.70	1.88	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	266.00	22.14	1.02	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	293.82	26.22	0.96	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	428.98	26.65	1.55	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	255.00	23.73	0.69	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	369.54	31.68	0.82	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	358.76	22.50	1.36	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	337.79	29.59	0.74	2.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	310.00	27.19	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	285.52	16.45	1.11	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	243.10	19.05	1.67	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	340.40	22.77	0.60	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	272.45	17.14	0.94	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	245.95	18.17	1.05	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	205.81	18.74	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	308.17	20.68	1.22	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	397.07	32.31	2.33	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	233.03	17.04	1.22	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	310.44	16.88	1.21	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	184.34	11.31	0.90	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	243.53	15.28	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	240.87	19.60	1.53	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	201.07	16.01	0.43	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	216.95	10.82	0.00	1.80
Schwann Cells, donor1	11498-119F4	70.71	5.45	0.94	1.88
Schwann Cells, donor2	11578-120F3	210.95	17.01	0.00	0.00
Schwann Cells, donor3	11659-122F3	136.27	13.58	0.00	1.31
Sebocyte, donor1	11220-116B5	235.54	30.68	0.55	0.00
Sebocyte, donor2	11301-117B5	232.08	18.84	0.00	0.00
Sebocyte, donor3	11378-118B1	102.85	11.13	0.21	0.00
Sertoli Cells, donor1	11255-116F4	139.15	18.22	1.66	0.00
Sertoli Cells, donor2	11333-117F1	158.16	14.12	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	117.63	21.11	0.18	1.85
Skeletal Muscle Cells, donor2	11358-117H8	28.91	1.45	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	91.13	8.36	1.67	1.67
Skeletal Muscle Cells, donor4	11451-119A2	254.33	23.09	0.31	1.10
Skeletal Muscle Cells, donor5	11455-119A6	244.22	23.49	0.59	1.49
Skeletal Muscle Cells, donor6	11459-119B1	287.95	22.47	0.77	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	216.35	29.49	0.25	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	187.49	19.12	0.29	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	288.11	25.99	0.30	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	204.65	33.36	0.08	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	47.04	2.90	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	46.65	6.19	0.14	1.10
Skin - palm, donor1	10286-104F7	61.78	10.74	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	97.59	5.05	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	138.22	3.27	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	128.66	7.79	0.00	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	153.88	18.07	0.28	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	81.16	7.74	0.42	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	126.87	10.57	0.42	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	86.79	9.44	0.15	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	212.31	13.89	0.00	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	102.05	7.34	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.14	6.47	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	51.71	8.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	64.58	7.88	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	66.44	9.27	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	157.12	23.02	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	60.68	11.84	0.13	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	159.81	21.28	0.00	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	81.04	9.86	0.00	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	125.03	19.86	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	148.84	28.65	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	98.37	9.11	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	46.04	4.55	0.16	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	84.63	14.61	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	57.84	6.57	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	62.47	3.34	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	145.11	22.71	0.15	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	155.40	14.42	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	170.66	17.11	0.00	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	49.96	6.81	0.00	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	57.13	6.47	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	75.91	5.98	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	65.21	8.88	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	213.05	24.03	0.00	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	148.95	19.52	0.30	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	161.33	14.79	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	69.44	3.02	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	460.71	58.55	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	160.59	25.70	0.27	1.86
Smooth Muscle Cells - Prostate, donor2	11335-117F3	148.26	20.54	0.75	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	83.20	14.97	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	107.20	12.97	0.15	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	54.76	5.25	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	11.63	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	73.95	9.30	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	139.35	13.63	0.00	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	66.44	2.51	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	30.09	5.01	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	248.42	40.49	0.17	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	90.63	8.88	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	53.25	6.91	0.14	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	91.27	9.18	0.00	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	63.93	8.27	0.19	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	207.80	23.76	0.14	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	158.44	22.96	0.17	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	36.67	0.95	0.00	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.83	5.87	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	138.76	15.91	0.22	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	158.29	15.80	0.29	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.41	8.36	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	90.18	7.14	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	146.18	17.48	0.00	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	108.88	13.30	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	90.00	7.10	0.00	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	200.48	18.12	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	95.49	11.94	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	58.70	5.99	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	71.06	7.94	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	84.80	10.08	0.46	0.46
Synoviocyte, donor1	11291-117A4	147.95	17.17	0.34	0.34
Synoviocyte, donor2	11368-117I9	104.09	14.42	0.17	0.34
Synoviocyte, donor3	11440-118H9	88.92	12.29	0.00	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	121.85	14.29	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	39.64	5.95	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	57.89	5.56	0.00	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	77.28	8.96	0.00	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	61.46	3.48	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	50.97	4.01	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	146.03	18.58	0.37	0.37
Urethra, donor2	10319-105A4	77.33	14.39	0.00	0.00
Urothelial Cells, donor1	11520-119H8	45.43	5.84	0.27	0.27
Urothelial Cells, donor2	11600-120H7	60.08	2.80	0.00	0.40
Urothelial Cells, donor3	11681-122H7	39.42	3.21	0.23	0.23
Urothelial cells, donor0	11216-116B1	165.61	16.94	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	184.19	28.47	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	130.09	17.16	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	97.89	15.74	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	133.26	25.14	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	152.23	22.66	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	140.57	18.74	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	174.38	22.03	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	105.90	8.22	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	294.59	38.74	0.74	2.22
Wilms' tumor cell line:HFWT	10597-108E3	55.44	10.56	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	255.86	24.02	0.56	1.68
achilles tendon, donor2	10292-104G4	72.33	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	409.20	30.34	0.76	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	526.34	79.17	0.00	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	362.06	43.21	1.42	2.37
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	606.54	76.74	1.63	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	661.11	62.68	1.12	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	467.80	64.29	0.21	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	350.88	19.87	1.91	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	330.04	43.62	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	500.65	56.76	0.41	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	276.47	32.62	0.78	3.88
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	640.87	67.34	0.37	3.86
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	374.45	31.20	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	508.45	46.01	0.46	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	577.35	54.89	1.04	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	384.89	43.84	0.88	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	278.39	25.10	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	345.45	33.31	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	63.54	8.90	0.31	3.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	331.13	52.49	0.85	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	323.92	60.96	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	403.90	74.62	0.48	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	514.97	48.11	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	391.25	41.36	0.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	310.32	37.16	3.72	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	547.29	60.64	1.13	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	349.34	42.30	0.44	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	131.21	26.24	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	134.94	20.25	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	73.06	11.32	0.00	0.31
adipose, donor1	10184-103D4	506.66	59.81	2.35	4.10
adipose, donor2	10185-103D5	75.43	10.14	0.81	2.84
adipose, donor3	10186-103D6	148.40	20.42	1.91	3.81
adipose, donor4	10187-103D7	308.56	30.34	0.00	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	168.71	29.99	0.32	0.95
adrenal gland, adult, pool1	10081-102A9	69.12	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	115.13	14.94	1.20	3.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	142.92	15.72	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	122.18	9.04	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	179.19	31.44	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	144.65	11.78	0.00	0.88
amygdala - adult, donor10196	10167-103B5	101.98	10.67	0.00	1.19
amygdala, adult, donor10252	10151-102I7	105.84	17.24	0.20	1.42
amygdala, newborn, donor10223	10360-105E9	73.91	10.33	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	97.28	14.64	0.25	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	355.42	31.11	0.66	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	216.12	29.06	0.33	2.34
aorta, adult, pool1	10052-101G7	73.75	10.00	0.20	0.39
appendix, adult	10189-103D9	143.60	16.69	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	288.91	23.39	0.69	2.06
artery, adult	10190-103E1	150.81	17.66	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	257.86	35.06	0.87	0.29
b cell line:RPMI1788	10427-106D4	173.09	30.93	0.30	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	158.98	18.59	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	197.77	29.97	0.10	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	112.48	19.08	0.50	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	143.72	21.81	0.56	1.12
bladder, adult, pool1	10011-101C2	94.19	12.82	0.11	0.33
blood, adult, pool1	10053-101G8	64.22	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	76.21	10.28	0.00	1.71
bone marrow, adult	10192-103E3	297.60	20.24	1.35	2.02
brain, adult, donor1	10084-102B3	67.65	17.43	0.00	4.10
brain, adult, pool1	10012-101C3	95.21	21.71	0.11	0.78
brain, fetal, pool1	10085-102B4	101.51	21.37	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	169.48	18.50	0.33	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	253.76	48.43	1.50	1.50
breast, adult, donor1	10080-102A8	60.61	7.58	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	198.31	34.05	0.38	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	159.25	24.74	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	555.06	80.58	0.46	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	393.39	51.08	1.94	2.91
carcinoid cell line:NCI-H1770	10703-109H1	201.23	21.63	1.88	1.41
carcinoid cell line:NCI-H727	10735-110B6	116.27	13.67	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	303.59	27.25	1.27	5.70
carcinosarcoma cell line:JHUCS-1	10642-109A3	292.80	36.47	3.73	9.85
caudate nucleus - adult, donor10196	10177-103C6	78.29	10.36	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	104.58	18.07	0.00	1.34
caudate nucleus, adult, donor10258	10379-105H1	90.17	15.28	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	116.83	10.25	0.00	3.30
cerebellum - adult, donor10196	10173-103C2	136.92	26.22	0.00	5.83
cerebellum, adult, donor10252	10166-103B4	170.17	29.46	1.28	4.91
cerebellum, adult, pool1	10083-102B2	91.07	13.11	0.34	2.41
cerebellum, newborn, donor10223	10357-105E6	177.68	27.40	0.00	5.81
cerebral meninges, adult	10188-103D8	96.32	16.64	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	81.86	6.58	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	192.24	30.48	0.14	0.58
cervical cancer cell line:ME-180	10553-107I4	185.27	26.35	1.16	0.83
cervix, adult, pool1	10013-101C4	132.29	20.79	0.00	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	113.14	22.99	0.84	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	2.61	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	228.05	30.82	0.37	1.49
choriocarcinoma cell line:SCH	10785-110H2	163.75	29.82	0.74	1.72
choriocarcinoma cell line:T3M-3	10618-108G6	119.30	16.37	0.00	0.95
chorionic membrane cells, donor1	12238-129G6	94.88	12.25	0.57	0.85
chorionic membrane cells, donor2	12239-129G7	132.64	16.70	0.40	0.50
chorionic membrane cells, donor3	12240-129G8	145.61	15.39	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	562.46	40.39	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	260.87	44.37	0.58	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	236.11	35.90	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	259.88	25.94	0.00	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	273.81	26.61	1.21	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	287.50	28.30	0.61	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	291.51	39.16	1.18	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	358.88	52.39	0.52	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	248.47	32.23	0.46	1.37
clear cell carcinoma cell line:TEN	10636-108I6	145.75	16.83	0.17	0.69
colon carcinoma cell line:CACO-2	10513-107D9	459.62	44.48	2.38	1.65
colon carcinoma cell line:COLO-320	10420-106C6	599.77	67.65	0.38	4.56
colon, adult, donor1	10082-102B1	83.30	13.09	1.19	1.19
colon, adult, pool1	10014-101C5	115.27	14.81	0.59	0.00
colon, fetal, donor1	10070-101I7	85.90	4.94	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	45.84	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	375.55	75.11	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	198.44	21.67	1.27	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	361.33	46.34	0.91	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	416.97	53.58	0.85	2.12
corpus callosum, adult, pool1	10042-101F6	119.74	27.97	0.11	0.88
cruciate ligament, donor2	10295-104G7	79.43	8.92	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	91.49	9.63	0.00	1.61
diencephalon, adult	10193-103E4	83.52	11.04	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	562.09	41.10	0.69	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	212.84	31.29	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	94.36	5.54	0.48	0.96
ductus deferens, adult	10196-103E7	118.11	17.44	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	115.22	10.08	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	211.13	18.39	0.00	0.00
dura mater, adult, donor1	10041-101F5	108.60	25.27	0.17	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	278.26	15.55	4.00	5.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	653.42	51.59	3.15	5.02
embryonic pancreas cell line:1B2C6	10604-108F1	53.65	6.17	0.00	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	70.83	11.50	0.30	2.42
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.13	11.73	0.31	0.93
embryonic pancreas cell line:2C6	10603-108E9	42.03	15.76	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	152.18	19.44	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	189.21	39.69	0.54	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	268.08	27.34	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	283.79	30.90	0.44	1.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	400.57	37.40	0.99	1.10
epididymis, adult	10197-103E8	116.17	21.35	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	71.14	15.08	0.18	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	46.01	6.29	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	314.26	29.62	0.92	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	249.59	25.29	0.59	2.07
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	306.18	30.14	1.12	2.58
esophagus, adult, pool1	10015-101C6	120.94	17.94	0.00	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	174.08	34.82	0.63	1.75
eye - muscle inferior rectus, donor1	10272-104E2	72.44	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	105.21	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	59.53	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	89.43	8.03	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	80.16	4.37	0.00	1.46
eye, fetal, donor1	10054-101G9	138.81	16.02	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	202.85	26.41	0.38	2.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	167.62	21.61	0.24	1.66
frontal lobe, adult, pool1	10040-101F4	112.03	25.33	0.19	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	217.08	30.02	1.50	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	170.35	26.33	0.27	0.91
gall bladder, adult	10198-103E9	99.71	15.45	0.00	0.72
gamma delta positive T cells, donor1	11937-126A2	192.73	38.12	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	183.76	30.25	0.75	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	136.45	15.84	0.42	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	79.30	11.22	0.00	1.55
gastric cancer cell line:AZ521	10549-107H9	339.55	51.32	0.98	3.77
gastric cancer cell line:GSS	10560-108A2	211.42	15.56	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	252.22	15.76	1.37	1.14
giant cell carcinoma cell line:LU65	10487-107B1	170.73	21.11	0.92	2.52
giant cell carcinoma cell line:Lu99B	10433-106E1	135.06	25.75	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	163.37	25.44	0.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	114.52	13.41	0.11	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	106.73	15.31	0.42	0.84
glioblastoma cell line:T98G	10485-107A8	226.15	44.70	0.77	1.21
glioma cell line:GI-1	10413-106B8	140.87	23.72	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	86.01	11.66	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	113.26	18.06	0.00	1.46
globus pallidus, adult, donor10258	10367-105F7	116.38	12.32	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	101.25	8.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	63.63	4.89	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	251.35	76.50	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	297.92	52.27	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	67.20	6.08	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	510.08	26.63	1.38	3.21
hIPS +CCl2, biol_rep2	14384-156C1	562.89	22.41	0.00	3.20
hIPS +CCl2, biol_rep3	14385-156C2	475.98	14.81	1.93	4.51
hIPS, biol_rep1	14380-156B6	582.10	8.62	0.00	2.87
hIPS, biol_rep2	14381-156B7	456.10	13.03	1.37	2.74
hIPS, biol_rep3	14382-156B8	126.90	11.03	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	218.09	27.01	1.72	4.31
heart - mitral valve, adult	10205-103F7	101.65	15.55	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	140.67	17.52	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	105.75	9.16	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	115.50	17.55	0.00	1.22
heart, adult, diseased, donor1	10051-101G6	92.41	11.50	0.00	0.85
heart, adult, pool1	10016-101C7	53.81	9.66	0.00	0.00
heart, fetal, pool1	10046-101G1	195.91	25.57	0.10	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	75.90	9.26	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	145.08	8.32	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	444.30	31.60	4.09	2.98
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	437.67	30.95	2.55	2.91
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	478.99	35.47	2.83	2.02
hepatoma cell line:Li-7	10484-107A7	101.43	15.79	0.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	358.18	36.98	0.50	0.90
hippocampus - adult, donor10196	10169-103B7	91.79	17.03	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	105.93	17.14	0.61	1.43
hippocampus, adult, donor10258	10374-105G5	109.55	5.98	0.00	1.99
hippocampus, newborn, donor10223	10363-105F3	69.44	8.81	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	869.74	66.53	1.83	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	478.52	37.90	1.37	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	509.31	37.58	1.02	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	197.92	24.25	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	249.17	27.37	1.55	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	303.31	27.33	0.38	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	157.65	23.94	3.80	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	169.54	26.28	1.72	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	160.57	24.19	2.09	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	315.88	49.96	1.89	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	255.54	36.96	3.21	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	311.74	45.78	2.69	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	416.09	30.51	1.41	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	489.33	34.39	1.47	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	953.92	36.66	2.62	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	231.77	29.21	1.53	3.82
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	210.62	26.16	2.18	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	249.88	24.99	3.00	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	142.42	20.35	0.57	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	161.42	23.65	2.27	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	135.32	16.91	0.63	4.07
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	186.49	25.64	1.14	2.78
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	191.89	26.13	0.58	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	156.04	21.52	1.49	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	497.33	36.58	1.29	4.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	412.81	34.52	2.00	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	693.72	51.86	1.63	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	281.31	35.21	1.06	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	207.46	31.36	0.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	254.50	26.03	0.30	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	137.55	21.20	0.00	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	156.08	23.91	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	175.72	23.34	1.80	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	235.20	32.98	1.28	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	235.50	28.77	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	209.03	29.57	1.34	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	492.67	51.20	1.93	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	672.95	42.34	1.78	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	433.66	26.34	0.98	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	237.46	26.89	0.92	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2609.10	195.19	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	392.50	40.04	1.32	5.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	188.82	26.27	1.64	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	163.21	29.31	0.00	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	168.68	22.42	1.78	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	272.09	19.09	1.19	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	277.08	45.23	1.22	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	183.73	27.21	1.35	2.96
immature langerhans cells, donor1	11904-125F5	110.18	18.16	0.24	0.24
immature langerhans cells, donor2	11905-125F6	57.83	9.51	0.00	0.79
insula, adult, pool1	10039-101F3	119.90	28.86	0.28	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	151.19	20.48	0.33	0.00
kidney, adult, pool1	10017-101C8	142.78	19.93	0.20	0.10
kidney, fetal, pool1	10045-101F9	155.27	22.21	0.21	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	83.79	9.66	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	108.24	10.78	0.14	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	316.17	29.91	0.73	3.12
left atrium, adult, donor1	10079-102A7	80.09	14.17	0.00	0.00
left ventricle, adult, donor1	10078-102A6	87.48	9.10	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	143.37	26.54	0.27	1.92
leiomyoma cell line:10964C	10569-108B2	99.87	7.18	0.00	0.72
leiomyoma cell line:15242A	10570-108B3	123.37	7.61	0.54	0.54
leiomyoma cell line:15425	10571-108B4	129.91	13.60	0.00	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	120.64	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	97.24	12.55	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	270.71	24.91	0.12	0.71
liposarcoma cell line:KMLS-1	10782-110G8	118.25	10.47	0.16	0.62
liposarcoma cell line:SW 872	10726-110A6	145.72	17.54	0.37	1.10
liver, adult, pool1	10018-101C9	181.83	18.31	0.65	0.49
liver, fetal, pool1	10086-102B5	69.61	9.41	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	75.10	11.37	0.29	0.73
locus coeruleus, adult, donor10252	10165-103B3	98.55	17.16	0.92	0.92
locus coeruleus, adult, donor10258	10375-105G6	64.05	12.98	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	190.54	16.40	1.26	2.10
lung adenocarcinoma cell line:A549	10499-107C4	99.09	17.58	0.14	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	98.59	16.55	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	114.81	15.82	0.00	0.26
lung, adult, pool1	10019-101D1	77.61	13.82	0.12	0.71
lung, fetal, donor1	10068-101I5	334.21	38.24	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	88.89	15.12	0.00	0.92
lymph node, adult, donor1	10077-102A5	95.15	13.25	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	149.70	23.45	0.44	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	544.54	66.11	0.15	1.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	317.71	42.47	1.70	0.85
mature adipocyte, donor1	12231-129F8	65.71	11.10	0.00	0.00
mature adipocyte, donor2	12232-129F9	79.28	11.21	0.00	0.00
mature adipocyte, donor3	12233-129G1	65.90	14.46	0.24	0.24
mature adipocyte, donor4	12234-129G2	105.81	19.74	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	105.55	26.21	0.24	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	112.80	12.41	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	104.83	16.18	0.37	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	69.57	9.85	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	221.77	25.59	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	112.05	18.56	0.17	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	114.81	16.77	0.21	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	57.79	13.48	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	301.43	57.41	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	75.38	8.97	0.36	1.08
medulla oblongata - adult, donor10196	10174-103C3	62.30	16.22	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	106.81	15.64	0.31	0.93
medulla oblongata, adult, pool1	10038-101F2	99.34	20.90	0.08	0.57
medulla oblongata, newborn, donor10223	10361-105F1	109.36	11.80	0.35	1.39
medulloblastoma cell line:D283 Med	10838-111E1	431.97	39.19	0.66	1.99
medulloblastoma cell line:ONS-76	10759-110E3	172.77	22.38	0.00	0.73
melanoma cell line:COLO 679	10514-107E1	57.50	8.62	0.00	0.29
melanoma cell line:G-361	10465-106H6	136.82	22.80	0.27	1.63
meningioma cell line:HKBMM	10691-109F7	94.97	10.13	0.36	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	509.31	59.92	4.41	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	425.64	44.33	3.89	3.63
mesenchymal precursor cell - adipose, donor1	11747-123G1	240.74	27.62	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	135.43	15.63	0.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	207.05	11.18	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	99.03	11.10	0.14	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	104.18	12.32	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	127.71	5.55	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	103.32	11.84	0.17	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	121.00	13.00	0.23	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	194.98	20.03	0.27	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	190.95	19.99	0.41	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	190.21	16.93	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	74.10	8.89	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	156.78	18.54	0.00	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	168.96	11.17	0.00	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	120.25	12.86	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	84.11	9.71	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	106.45	10.86	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	93.48	7.30	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	289.49	20.56	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	133.00	14.64	0.00	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	128.93	14.36	0.09	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	103.45	7.36	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	100.16	5.72	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	345.65	34.10	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	115.54	11.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	136.59	14.58	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	121.72	13.61	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	111.84	13.25	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	139.09	16.95	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	131.66	11.51	0.68	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	121.43	14.54	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	119.55	16.22	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	386.43	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	142.77	16.73	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	127.39	12.27	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	140.61	15.86	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	140.07	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	118.15	13.43	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	146.56	14.74	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	134.02	18.04	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	106.64	13.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	92.97	15.49	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	129.59	11.69	0.32	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	77.11	10.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	135.40	17.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	127.57	9.00	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	106.12	13.61	0.39	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	109.13	6.30	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	109.28	8.94	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	104.88	28.60	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	101.99	14.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	115.75	13.40	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	134.91	12.03	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	86.23	10.69	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	90.27	19.34	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	79.84	11.98	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	96.43	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	99.42	8.96	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	85.80	6.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	85.48	6.48	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	89.46	9.66	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	69.51	9.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	99.34	15.37	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	105.29	12.84	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	114.27	12.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	158.83	22.76	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	126.73	12.34	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	142.48	13.99	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	137.42	18.54	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	159.18	10.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	105.17	10.14	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	106.21	13.96	0.61	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	189.80	18.08	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	117.79	5.77	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	116.67	17.46	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	109.03	14.93	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	91.68	10.19	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	70.41	5.42	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	77.72	19.84	0.47	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	173.99	31.51	0.46	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	132.48	8.55	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	256.26	18.19	0.21	1.03
mesothelioma cell line:Mero-25	10850-111F4	154.78	19.97	0.91	2.50
mesothelioma cell line:Mero-41	10851-111F5	193.14	22.25	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	130.42	10.19	0.22	1.33
mesothelioma cell line:Mero-82	10853-111F7	181.07	15.51	0.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	135.67	8.17	0.17	0.68
mesothelioma cell line:Mero-84	10855-111F9	121.58	9.86	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	100.62	8.90	0.00	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	238.70	14.58	0.66	0.99
mesothelioma cell line:NCI-H226	10846-111E9	156.74	11.04	0.18	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	167.41	20.33	1.02	2.22
mesothelioma cell line:NCI-H28	10845-111E8	261.34	31.81	0.76	3.05
mesothelioma cell line:No36	10857-111G2	171.91	17.61	1.63	0.65
mesothelioma cell line:ONE58	10858-111G3	194.54	12.19	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	296.52	35.12	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	139.58	13.43	0.00	0.49
migratory langerhans cells, donor3	11903-125F4	183.97	20.10	0.18	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	84.88	8.49	0.65	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	132.88	10.60	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	105.04	13.13	0.46	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	156.80	22.26	0.57	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	560.84	99.42	0.74	1.85
myeloma cell line:PCM6	10474-106I6	75.51	14.23	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	124.79	7.61	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	100.82	4.90	0.98	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	141.84	21.39	0.67	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	172.53	24.86	0.44	0.96
nasal epithelial cells, donor2	12227-129F4	98.25	18.22	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	230.29	40.03	1.61	3.68
neuroblastoma cell line:NB-1	10539-107G8	383.34	58.37	1.50	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	275.63	32.48	0.84	2.53
neuroblastoma cell line:NH-12	10555-107I6	331.89	25.16	0.93	3.54
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	145.18	15.18	0.00	3.56
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	176.75	29.14	0.48	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	258.42	37.23	0.81	2.42
neuroepithelioma cell line:SK-N-MC	10728-110A8	125.25	15.89	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	96.62	12.78	0.00	0.80
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	151.53	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	389.99	56.49	0.51	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	204.13	32.82	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	104.20	15.39	0.32	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	142.94	21.28	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	100.21	24.09	0.19	0.37
occipital cortex - adult, donor10196	10172-103C1	100.96	16.48	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	114.86	16.64	1.07	1.61
occipital cortex, newborn, donor10223	10355-105E4	105.91	10.55	0.00	1.46
occipital lobe, adult, donor1	10076-102A4	104.96	18.11	0.26	1.84
occipital lobe, fetal, donor1	10073-102A1	96.98	25.32	0.00	1.29
occipital pole, adult, pool1	10036-101E9	85.15	18.84	0.39	0.79
olfactory region, adult	10195-103E6	101.45	15.86	0.00	0.96
optic nerve, donor1	10277-104E7	84.04	14.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	139.31	24.95	0.34	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	258.15	36.54	0.69	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	560.80	46.06	0.00	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	164.48	14.21	0.00	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	69.96	9.11	0.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	139.22	15.88	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	255.11	33.08	1.27	0.85
ovary, adult, pool1	10020-101D2	102.64	13.98	0.09	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	158.21	11.00	0.00	0.37
pancreas, adult, donor1	10049-101G4	113.82	16.93	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	85.82	12.30	0.28	1.96
papillary adenocarcinoma cell line:8505C	10437-106E5	198.80	22.32	0.51	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	229.33	23.84	0.33	0.66
paracentral gyrus, adult, pool1	10035-101E8	98.66	24.25	0.37	0.92
parietal cortex, adult, donor10258	10373-105G4	96.89	13.21	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	97.81	15.99	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	105.46	17.96	0.29	1.71
parietal lobe, adult, pool1	10034-101E7	93.41	23.97	0.35	1.15
parietal lobe, fetal, donor1	10072-101I9	158.08	25.22	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	115.90	8.97	0.75	1.50
parotid gland, adult	10199-103F1	110.38	20.35	0.00	0.00
penis, adult	10200-103F2	123.54	7.52	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	251.01	26.22	0.00	2.42
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	187.22	29.14	0.58	1.02
pineal gland - adult, donor10196	10179-103C8	79.34	10.97	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	131.47	18.36	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	107.86	16.30	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	190.22	17.20	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	234.53	33.36	0.52	4.17
pituitary gland, adult, donor10258	10378-105G9	183.87	22.13	0.85	1.70
placenta, adult, pool1	10021-101D3	114.60	15.80	0.22	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	280.88	30.06	0.79	1.99
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	143.97	18.99	0.16	0.31
pons, adult, pool1	10033-101E6	83.66	22.29	0.00	0.95
postcentral gyrus, adult, pool1	10032-101E5	100.16	19.70	0.17	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	275.40	60.59	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	281.66	82.15	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	152.94	21.56	0.44	0.58
prostate cancer cell line:PC-3	10439-106E7	192.57	34.67	0.91	1.63
prostate, adult, pool1	10022-101D4	100.76	15.96	0.18	0.45
putamen, adult, donor10196	10176-103C5	102.92	19.36	0.00	0.24
putamen, adult, donor10252	10152-102I8	94.11	17.65	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	274.30	9.84	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	78.77	13.77	0.48	0.00
putamen, newborn, donor10223	10365-105F5	235.39	23.99	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	121.61	15.71	0.00	0.29
rectum, fetal, donor1	10067-101I4	97.37	11.13	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	252.49	41.76	0.85	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	67.93	9.94	0.83	1.24
retina, adult, pool1	10030-101E3	126.54	24.95	0.10	0.70
retinoblastoma cell line:Y79	10475-106I7	388.14	51.44	0.78	2.86
rhabdomyosarcoma cell line:KYM-1	10787-110H4	193.52	29.51	0.49	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	206.12	30.65	0.56	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	53.81	6.82	0.00	0.76
salivary acinar cells, donor1	11771-123I7	155.38	17.32	0.16	0.97
salivary acinar cells, donor2	11772-123I8	136.31	18.73	0.00	1.10
salivary acinar cells, donor3	11773-123I9	66.87	7.28	0.00	0.66
salivary gland, adult, pool1	10093-102C3	201.90	28.03	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	68.12	8.60	0.25	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	60.54	11.40	0.00	1.29
seminal vesicle, adult	10201-103F3	105.29	19.05	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	245.60	18.71	1.21	2.92
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	123.80	10.82	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	339.19	22.08	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	312.97	20.82	0.94	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	187.34	30.95	0.77	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	202.96	14.97	0.65	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	156.76	12.06	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	138.17	16.43	0.24	0.84
skeletal muscle, fetal, donor1	10066-101I3	65.33	9.05	0.00	0.00
skin, adult, donor1	10074-102A2	108.56	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	128.77	15.15	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	201.11	41.69	1.00	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	182.50	16.08	0.63	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	257.70	52.81	0.19	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	253.17	37.25	1.15	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	389.90	25.74	0.16	3.38
small cell lung carcinoma cell line:WA-hT	10562-108A4	150.80	14.16	1.53	0.65
small intestine, adult, pool1	10024-101D6	166.86	20.90	1.07	0.36
small intestine, fetal, donor1	10064-101I1	163.14	20.88	0.74	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	170.28	11.28	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	96.66	11.63	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	85.77	11.26	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	84.42	10.09	0.00	1.15
spinal cord, adult, donor10252	10159-103A6	86.35	15.38	0.00	1.97
spinal cord, adult, donor10258	10369-105F9	138.36	10.38	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	120.14	22.56	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	151.54	22.96	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	96.48	12.99	0.00	0.60
spleen, adult, pool1	10025-101D7	112.45	19.16	0.22	0.22
spleen, fetal, pool1	10044-101F8	117.20	17.56	0.08	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	198.02	23.29	0.21	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	109.18	22.97	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	215.61	34.25	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	96.17	3.91	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	199.90	25.21	0.11	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	248.23	26.69	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	269.92	17.77	0.85	0.42
stomach, fetal, donor1	10062-101H8	95.05	14.95	0.00	1.07
submaxillary gland, adult	10202-103F4	137.86	18.80	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	93.88	15.58	0.00	1.45
substantia nigra, adult, donor10258	10371-105G2	117.42	7.24	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	86.20	10.60	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	355.59	55.71	0.46	1.15
temporal lobe, adult, pool1	10031-101E4	88.25	21.70	0.00	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	143.17	24.93	0.00	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	156.92	26.81	0.00	0.44
tenocyte, donor1	11763-123H8	159.89	19.55	0.00	0.70
tenocyte, donor2	11765-123I1	83.93	10.30	0.00	0.00
tenocyte, donor3	11768-123I4	132.33	11.86	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	469.43	40.45	0.68	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	270.07	22.51	2.00	1.23
teratocarcinoma cell line:PA-1	10807-111A6	337.23	33.01	0.46	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	310.26	21.45	0.38	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	385.74	23.07	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	327.30	26.94	0.33	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	377.16	45.60	0.33	2.93
testis, adult, pool1	10026-101D8	92.88	16.32	0.43	1.40
testis, adult, pool2	10096-102C6	114.58	9.92	1.35	7.67
thalamus - adult, donor10196	10168-103B6	93.84	13.25	0.00	1.10
thalamus, adult, donor10252	10154-103A1	112.84	18.44	0.00	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	113.93	6.16	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	54.02	6.92	0.00	0.66
thalamus, newborn, donor10223	10366-105F6	101.83	11.51	0.58	1.73
throat, adult	10209-103G2	161.04	20.47	0.00	0.00
throat, fetal, donor1	10061-101H7	126.15	23.46	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	490.27	49.09	0.60	0.99
thymus, adult, pool1	10027-101D9	185.21	25.45	0.10	1.79
thymus, fetal, pool1	10043-101F7	193.26	28.26	0.73	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	290.39	19.28	0.40	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	154.36	19.98	0.00	1.26
thyroid, adult, pool1	10028-101E1	163.67	24.54	0.28	0.47
thyroid, fetal, donor1	10060-101H6	125.24	25.31	0.79	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	3.08	0.00	0.00
tongue, adult	10203-103F5	206.99	18.37	0.23	0.70
tongue, fetal, donor1	10059-101H5	178.13	18.92	0.39	1.18
tonsil, adult, pool1	10047-101G2	159.78	27.05	0.40	0.60
trachea, adult, pool1	10029-101E2	112.31	18.00	0.00	0.49
trachea, fetal, donor1	10058-101H4	95.02	15.00	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	122.58	18.78	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	450.86	55.12	1.32	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	157.31	26.32	0.63	2.51
tridermal teratoma cell line:HGRT	10694-109G1	53.27	7.61	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	112.92	15.66	0.25	1.44
umbilical cord, fetal, donor1	10057-101H3	114.76	8.35	0.00	2.09
uterus, adult, pool1	10100-102D1	151.69	19.45	0.17	1.19
uterus, fetal, donor1	10055-101H1	133.10	17.41	0.00	0.00
vagina, adult	10204-103F6	78.19	5.82	0.00	0.65
vein, adult	10191-103E2	108.50	15.56	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	126.31	15.49	0.00	1.87